Thyrocare Technologies Schedules Q3FY26 Earnings Conference Call for January 28, 2026

Thyrocare technologies has scheduled an earnings conference call for January 28, 2026, at 5:30 PM IST to discuss its unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement was made on January 20, 2026, pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Conference Call Details

The earnings call will provide analysts and investors an opportunity to interact with the company's senior management team regarding Q3FY26 performance. Multiple access options have been arranged to accommodate participants.

Access Method:	Details
Date & Time:	Wednesday, January 28, 2026, 5:30 PM IST
Universal Access Numbers:	+91 22 6280 1408, +91 22 7115 8296
Early Registration:	Available via online portal
Webcast Link:	Live streaming option provided

Management Participation

The conference call will be conducted by key members of Thyrocare Technologies' senior management team who will present the financial results and address questions from participants.

Position:	Name
MD & CEO:	Mr. Rahul Guha
CFO:	Mr. Vikram Gupta
Manager - Strategy & Investor Relations:	Mr. Preet Joshi

Regulatory Compliance

The earnings call announcement was formally communicated to both the National Stock Exchange of India Limited and BSE Limited. Company Secretary and Compliance Officer Brijesh Kumar signed the regulatory filing, ensuring compliance with listing obligations.

Exchange:	Symbol/Code
NSE:	THYROCARE
BSE:	539871

The conference call represents the company's commitment to maintaining transparent communication with its stakeholders regarding quarterly financial performance and business developments.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.43%	+4.75%	+8.56%	+20.09%	+69.47%	+50.36%

Thyrocare Technologies has announced a key leadership appointment with Rajdeep Panwar joining as Chief Commercial Officer. The appointment will be effective from January 05, 2026, marking a strategic addition to the company's senior management team.

Leadership Appointment Details

The new Chief Commercial Officer brings significant industry expertise to Thyrocare Technologies. Key details of the appointment include:

Parameter:	Details
Position:	Chief Commercial Officer
Appointee:	Rajdeep Panwar
Effective Date:	January 05, 2026
Industry Experience:	21 years
Sector Expertise:	Healthcare and Diagnostics

Professional Background

Rajdeep Panwar's appointment comes with substantial industry credentials, having accumulated 21 years of experience specifically in the healthcare and diagnostics sector. This extensive background positions him well to lead Thyrocare's commercial operations and drive business growth initiatives.

Strategic Implications

The appointment of an experienced professional to the Chief Commercial Officer role reflects Thyrocare Technologies' commitment to strengthening its leadership team. With Panwar's two decades of sector-specific experience, the company appears focused on enhancing its commercial strategy and market presence in the diagnostics industry.

This leadership addition comes as part of Thyrocare's ongoing efforts to build a robust management structure capable of navigating the competitive healthcare diagnostics landscape. The timing of the appointment, scheduled for early 2026, suggests strategic planning for the company's future commercial initiatives.